CATALOGO DEI PRODOTTI DELLA RICERCA

BERTOLDO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.619
NA - Nord America 4.616
AS - Asia 1.658
SA - Sud America 32
AF - Africa 18
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.956
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.603
GB - Regno Unito 1.912
CN - Cina 1.171
SE - Svezia 424
IT - Italia 420
FR - Francia 392
RU - Federazione Russa 359
IE - Irlanda 321
DE - Germania 305
FI - Finlandia 300
SG - Singapore 285
UA - Ucraina 102
TR - Turchia 56
ID - Indonesia 22
VN - Vietnam 21
HK - Hong Kong 20
JP - Giappone 20
BR - Brasile 18
RO - Romania 16
BE - Belgio 15
KR - Corea 15
NL - Olanda 13
CA - Canada 11
CZ - Repubblica Ceca 10
IN - India 10
IR - Iran 9
AU - Australia 7
CL - Cile 7
MY - Malesia 6
EG - Egitto 5
ES - Italia 5
TG - Togo 5
A2 - ???statistics.table.value.countryCode.A2??? 4
HU - Ungheria 4
IL - Israele 4
PK - Pakistan 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
HR - Croazia 3
LV - Lettonia 3
AR - Argentina 2
BD - Bangladesh 2
BG - Bulgaria 2
CO - Colombia 2
KE - Kenya 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
MX - Messico 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BO - Bolivia 1
CH - Svizzera 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
EU - Europa 1
IQ - Iraq 1
IS - Islanda 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SL - Sierra Leone 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 10.956
Salva come PNG Salva come JPEG
Città #
Southend 1.775
Jacksonville 978
Chandler 816
Ann Arbor 388
Woodbridge 377
Dublin 318
Houston 310
Ashburn 222
Singapore 187
Princeton 149
Lawrence 148
Wilmington 137
Beijing 126
Nanjing 123
Jinan 108
Shenyang 97
Verona 91
New York 82
Hebei 74
Sindelfingen 69
Changsha 65
Helsinki 59
Milan 59
Boardman 55
Nanchang 52
Ningbo 48
Tianjin 47
Zhengzhou 38
Bologna 37
Haikou 35
Jiaxing 33
Taizhou 32
Dearborn 27
Hangzhou 27
Lancaster 24
Jakarta 22
Falls Church 19
Tokyo 19
Norwalk 18
San Francisco 18
Chicago 17
Dong Ket 16
Brussels 15
Detroit 15
Fuzhou 15
Paris 15
Seattle 14
Seoul 14
Taiyuan 14
Guangzhou 13
London 13
Los Angeles 12
Redmond 12
Fairfield 10
Hong Kong 10
Lanzhou 10
Rome 10
Washington 10
Dallas 9
Cambridge 8
Florianópolis 8
Auburn Hills 7
Bârlad 7
Düsseldorf 6
Tübingen 6
Amsterdam 5
Brno 5
Clearwater 5
Des Moines 5
Kent 5
Las Vegas 5
Leawood 5
Lomé 5
Maple Grove 5
Messina 5
Moscow 5
Novokuznetsk 5
Capannoli 4
Catania 4
Central 4
Elora 4
Naples 4
Olomouc 4
Pioltello 4
Redwood City 4
Riva 4
Santa Clara 4
São Paulo 4
Tombolo 4
Toronto 4
Berlin 3
Binasco 3
Bratislava 3
Canberra 3
Costa Mesa 3
Dongguan 3
Esslingen am Neckar 3
Frankfurt am Main 3
Fresh Meadows 3
Greifswald 3
Totale 7.737
Salva come PNG Salva come JPEG
Nome #
Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro. 147
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 142
The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation 139
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 136
Incidenza di ipovitaminosi D nel Nord Italia 135
The effects on hTERT gene expression is an additional mechanism of amino-bisphosphonates in prostatic cancer cells 129
STEAP mRNA detection in serum of patients with solid tumours. 124
Gene expression analysis in osteoblastic differentiation from peripheral blood mesenchymal stem cells 120
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 118
Age-related bone loss in postmenopausal women 111
Bone metabolism in patients with anorexia nervosa and amenorrhoea 111
BISPHOSPHONATES DECREASE HTERT IN PC3 AND DU-145 PROSTATE CANCER CELLS 110
Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats. 110
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 109
Bone development during GH and GnRH analog treatment 107
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 107
Adipocytes IGFBP-2 expression in prepubertal obese children. 105
The renal handling of calcium: influence of parathyroid hormone secretion 104
Guidelines for the diagnosis, prevention and management of osteoporosis 104
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 103
Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment 101
Incidenza di ipovitaminosi D nel Nord Italia 99
Osteopenia induced by immunosuppressive drugs in rats. Histomorphometric analisys of risedronate effects. 98
A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: Prednisone versus Deflazacort. 98
Type VI Osteogenesis imperfecta: effect of plasma transfusion on bone metabolism 96
Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation. 96
YEARS BOOK 2006 . BISFOSFONATI E ONCOLOGIA 96
Bone microarchitecture evaluated by histomorphometry 96
Bone Microarchitecture in Mild Primary Hyperparathyroidism 95
The effect of bisphosphonates on gene expression: GAPDH as a housekeeping or a new target gene? 95
Blood ionized calcium is associated with clustered polymorphism in the carboxyl-terminal tail of the calcium-sensing receptor. 94
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 94
Altered bone metabolism in children infected with human immunodeficiency virus. 93
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 93
Bone mineral density and metabolism in HIV-infected children 92
Effects of two oral doses of alendronate in the treatment of Paget's disease of bone 92
PEAK BONE MASS AND BODY COMPOSITION IN PRECOCIOUS PUBERTY AFTER GNRH AGONIST THERAPY WITH AND WITHOUT CALCIUM SUPPLEMENTATION 92
Bisfosfonati e metastasi ossee:up-to-date 2005 92
Drug-induced osteonecrosis of the jaw: the state of the art 91
GAPDH: CONSTITUTIVE HOUSEKEEPING GENE OR TARGET FOR THERAPEUTIC INTERVENTION? 90
Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment 90
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 89
Regulation of calcium-parathyroid hormone feedback in primary htperparathyroidism effcts of bisphosphonate treatment 88
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 87
EFFETTO DI UN AGONISTA DEL GNRH AD AZIONE PROLUNGATA (LEUPROLIDE ACETATO) SULLO STATO DI MINERALIZZAZIONE OSSEA IN BAMBINE CON PUBERTA' PRECOCE 86
Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism. 86
Transdermal Estradiol in the treatment of postmenopausale bone loss. 85
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 85
CALCIUM SUPPLEMENTATION, OESTROGENS AND BONE DENSITY IN GNRHA TREATED PRECOCIOUS PUBERTY 84
Histomorphometric analysis of glucocorticoid-induced osteoporosis 84
Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism. 84
Effects of two oral doses of alendronate in the treatment of Paget’s disease of bone. 83
Final peak bone mass in precocious puberty after GhRH agonist therapy with and without calcium supplementation 82
the use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemnia of malignanacy 82
The epidemiology of osteoporosis in Italian postmenopausal women according to the National Bone Health Alliance (NBHA) diagnostic criteria: a multicenter cohort study 82
Transdermal estradiol in the treatment of postmenopausal bone loss. 81
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 81
Sodium requirements regulates renal tubular reabsorption of calcium 80
The use of dichloromethylene bisphosphonate and aminobutanebisphosphonate in hypercalcemia of malignancy. 79
intramuscolar neridronate in postmenopausal women with low bone mineral density 79
emerging drugs for the management of cancer treatment induced bone loss 79
The Effect of Bisphosphonates on Gene Expression: The GAPDH as a Housekeeping or a New Target Gene? 78
Relationship between serum calcium, sodium excretion and calcium excretion in normals and in patients with idiopathic hypercalcemia and with primary hyperparathyroidism 78
The prevention of corticosteroid-induced osteoporosis with nandrolone decantate Bone and Mineral 15, 72-81 (1991) 78
Acute effects of deflazacort and prednisone on rates of mineralization and bone formation 77
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 77
Valutazione della microarchitettura ossea nell'iperparatiroidismo primitivo 75
Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteopororis fractures 75
Effects of two oral doses of alendronate in the treatment of Paget’s Disease of bone 75
Relationship between serum calcium, sodium excretion and calcium excretion in normals and in patients with idiophatic hypercalciuria and primary hyperparathyroidism 74
Ruolo dei bisfosfonati nella terapia dell'osteoporosi 74
Prevalence of asymptomatic vertebral fractures in late-onset Pompe disease. 74
Bisphosphonates and osteonecrosis of the mandible/maxilla in osteoporosis: no reason to panic 73
Artropatie dismetaboliche 73
HIV-infected children and bone mineral density 72
Calcium Supplementation Increases Bone Mass in GH-Deficient Prepubertal Children during GH Replacement 72
ARTROPATIE DISMETABOLICHE 72
nUOVE PROSPETTIVE NELL'UTILIZZO DEI BISFOSFONATI IN ONCOLOGIA:OLTRE LA METASTASI OSSEA 72
Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle. 70
Obesità e osteoporosi 70
Osteomalacia: The missing link in the pathogenesis of Bisphosphonate-related osteonecrosis of the jaws? 70
Can we consider zoledronic acid a new antitumor agent? Recent evidence in clinical setting 70
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 70
L'osteoporosi cortisonica 69
Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control study. 68
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 68
Trabecular bone microarchitecture in mild primary hyperparathyroidism 67
Serum 25-hydroxy vitamin D and exercise capacity in COPD. 67
Treatment thresholds for osteoporosis and reimbursability criteria: perspectives associated with fracture risk-assessment tools. 67
Valutazione della perdita frazionaria di massa ossea dopo la menopausa. 66
Intramuscular neridronate in postmenopausal women with low bone mineral density 66
Physiopatology of bone metastases 66
Bone Metastases from Prostate Cancer.Biology, Diagnosis and Management 66
Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO) 66
Effetto dell'alendronato sulle caratteristiche strutturali e biomeccaniche dell'osso corticale 65
Prevenzione della demineralizzazione ossea mediante supplementazione con calcio durante il trattamento con agonisti del GnRH nella pubertà precoce 64
Definition of a population-specific DXA reference standard in Italian women: the Densitometric Italian Normative Study (DINS). 64
Fisiopatologia del dolore da metastasi ossea 64
Transforming Growth Factor-B1 gene polimorphism, bone turnover and bone mass in Italian postmenopausal women 63
Il trattamento medico dell`iperparatiroidismo primitivo. 63
Totale 8.758
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.054
article - articoli 33.525
book - libri 731
conference - conferenze 1.994
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.804
Totale 76.108
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.027 0 0 0 120 114 137 139 130 71 116 26 174
2020/20211.194 123 197 39 136 153 125 25 108 112 6 132 38
2021/20221.251 96 389 6 101 48 48 14 61 39 27 122 300
2022/20232.308 218 196 274 364 227 524 12 134 240 24 73 22
2023/20241.191 53 89 131 135 170 169 59 74 7 50 159 95
2024/2025672 188 199 113 172 0 0 0 0 0 0 0 0
Totale 11.092